Preparations are underway at the European Medicines Agency together with European Member States and the European Commission, for the introduction of the new pharmacovigilance legislation in July this year. The new legislation will represent the biggest change to the legal framework since The Agency was founded in 1995…
Lees meer..
Major blockbuster drugs are facing the end of their era and big pharma companies are bracing for the effect in hopes that they will find a solution for their dwindling pipelines. Thus new opportunities and challenges are rising in the practice of open innovation and Fleming Europe will be there to explore them…
Lees meer..
NextLevel Pharma’s “Advancing clinical research in Turkey, the Middle East and North Africa” conference will bring together the local regulators and ethics committees, alongside experienced investigators and study personnel, as well as clinical trial experts from pharma and CROs…
Lees meer..
A study published in this week’s PLoS Medicine shows that commercial electronic prescribing systems (commonly known as e-prescribing, in which prescribers use a computer to order medications for their patients through a system with the help of prompts, aids, and alerts) could substantially reduce prescribing error rates in hospital in-patients…
Lees meer..
Asian markets are increasingly the focus of pharmaceutical companies who are looking for new market opportunities beyond the traditional “rich-world” countries who are facing economic stagnation…
Lees meer..
This unique and timely event will highlight how different frameworks and initiatives have succeeded in developing an efficient, environmentally friendly manufacturing process in the pharmaceutical industry…
Lees meer..
Shortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a review published in Clinical Infectious Diseases and available online*…
Lees meer..
ComplianceOnline, the leading governance, risk and compliance advisory network with over 500 experts in various regulatory subjects, today announced a seminar on The A to Z’s of Microbial Control, Monitoring and Validation of Pharmaceutical Water Systems. The two day long, in-person seminar, led by well known water systems expert T.C…
Lees meer..
Orphan drug development has become more feasible than in previous years but we’ve barely scratched the surface: only 367 approved orphan drugs out of 6,800 rare diseases. We need to keep the momentum going. Come April 10-13, over 300 key decision makers from orphan drug manufacturers, patient groups, payers and regulators will gather in DC at the 2nd annual World Orphan Drug Congress USA…
Lees meer..
According to an investigation by researchers from the University of British Columbia, University of Toronto and the Institute for Clinical Evaluative Sciences published in CMAJ (Canadian Medical Association Journal), the cost of prescription medication affects 1 in 10 Canadians, and 1 in 4 individuals without medication insurance cannot afford to have their prescriptions filled…
Lees meer..